NCT00118144View on ClinicalTrials.gov

Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerNon-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG

bortezomib

Given IV

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00118144 - Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer | Biotech Hunter | Biotech Hunter